StockStory.org on MSN
ELAN Q1 deep dive: Innovation products and margin expansion steer strong start
Animal health company Elanco (NYSE:ELAN) reported Q1 CY2026 results , with sales up 14.9% year on year to $1.37 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results